GENELUX CORP - GNLX

Latest data: 6/13/2025 10:04:30 PM
EDGAR CIK 0001231457

Buy Breakdown

Total $0

Sell Breakdown

Total $182,531

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
05/12/2025
05/13/2025
VP, Pharmaceutical Development
Officer
Sell
-4,737 @ $2.92
($13,832.04)
52,266 (-8.31%) Direct
05/12/2025
05/13/2025
General Counsel
Officer
Sell
-4,475 @ $2.92
($13,067.00)
47,621 (-8.59%) Direct
05/12/2025
05/13/2025
Head of Regulatory
Officer
Sell
-1,259 @ $2.92
($3,676.28)
34,760 (-3.50%) Direct
05/12/2025
05/13/2025
VP, Clinical Trial Operations
Officer
Sell
-5,579 @ $2.92
($16,290.68)
47,640 (-10.48%) Direct
05/12/2025
05/13/2025
President and CEO
CEO Director
Sell
-10,764 @ $2.92
($31,430.88)
191,447 (-5.32%) Direct
12/30/2024
12/30/2024
Director
Sell
-3,460 @ $2.46
($8,511.60)
45,791 (-7.03%) Direct
12/16/2024
12/18/2024
VP, Pharmaceutical Development
Officer
Sell
-6,300 @ $2.34
($14,742.00)
14,653 (-30.07%) Direct
12/16/2024
12/18/2024
Head of Regulatory
Officer
Sell
-2,510 @ $2.34
($5,873.40)
16,322 (-13.33%) Direct
12/16/2024
12/18/2024
Chief Financial Officer
CFO
Sell
-2,103 @ $2.34
($4,921.02)
40,802 (-4.90%) Direct
12/16/2024
12/18/2024
President and CEO
CEO Director
Sell
-14,315 @ $2.34
($33,497.10)
37,372 (-27.70%) Direct
06/24/2024
07/08/2024
Head of Quality
Officer
Sell
-4,961 @ $2.12
($10,517.32)
16,174 (-23.47%) Direct
06/24/2024
07/08/2024
General Counsel
Officer
Sell
-5,496 @ $2.12
($11,651.52)
19,388 (-22.09%) Direct
06/24/2024
07/08/2024
VP, Clinical Trial Operations
Officer
Sell
-6,849 @ $2.12
($14,519.88)
10,869 (-38.66%) Direct